A review of the Haemophilia Joint Health Score (HJHS) reveals significant variability in its application across clinical ...

Symptom screening improved symptom scores among children with cancer compared with usual care, two randomized trials showed.

It means patients may experience delayed access to treatment. Dr. Mukul Singal, hematologist at the Indiana Hemophilia and ...

Adding a PD-1 inhibitor to standard of care improved disease-free survival (DFS) in stage III soft-tissue sarcoma of the ...

Reported 100% of Acute Myeloid Leukemia (AML) patients treated in INB-100 remain in complete remission (CR) at the 2024 ...

Hematology-Oncology Associates of CNY (HOA) announced that Natalie Hartigan, D.O., medical oncologist and hematologist, has ...

The certification is for products used in hematology instruments manufactured globally, including instruments from Abbott, Beckman Coulter, and Siemens Healthineers.

A recent meta-analysis investigating cardiovascular complications in adults undergoing chimeric antigen receptor (CAR) T-cell ...

Erin Wright, M.D., is the new chairholder of the Jeffrey A. Barbour Chair for Pediatric Hematology/Oncology Research and ...

The 65th annual Haematocon conference in Nagpur gathers over 40 international experts in haematology to discuss advancements ...

Stay updated on Beam Therapeutics Inc.'s latest advancements in Sickle Cell Disease and alpha-1 antitrypsin deficiency treatments. Click for my BEAM stock update.

Cellectar's lead product candidate, iopofosine I 131, is a potential first-in-class, novel cancer targeting agent utilizing a phospholipid ether as a radioconjugate. Iopofosine I 131 is an ...